Dominant Negative MyD88 Proteins Inhibit Interleukin-1β/Interferon-γ-mediated Induction of Nuclear Factor κB-dependent Nitrite Production and Apoptosis in β Cells*

Insulin-dependent diabetes mellitus is an autoimmune disease in which pancreatic islet β cells are destroyed by a combination of immunological and inflammatory mechanisms. In particular, cytokine-induced production of nitric oxide has been shown to correlate with β cell apoptosis and/or inhibition of insulin secretion. In the present study, we investigated whether the interleukin (IL)-1β intracellular signal transduction pathway could be blocked by overexpression of dominant negative forms of the IL-1 receptor interacting protein MyD88. We show that overexpression of the Toll domain or the lpr mutant of MyD88 in βTc-Tet cells decreased nuclear factor κB (NF-κB) activation upon IL-1β and IL-1β/interferon (IFN)-γ stimulation. Inducible nitric oxide synthase mRNA accumulation and nitrite production, which required the simultaneous presence of IL-1β and IFN-γ, were also suppressed by ∼70%, and these cells were more resistant to cytokine-induced apoptosis as compared with parental cells. The decrease in glucose-stimulated insulin secretion induced by IL-1β and IFN-γ was however not prevented. This was because these dysfunctions were induced by IFN-γ alone, which decreased cellular insulin content and stimulated insulin exocytosis. These results demonstrate that IL-1β is involved in inducible nitric oxide synthase gene expression and induction of apoptosis in mouse β cells but does not contribute to impaired glucose-stimulated insulin secretion. Furthermore, our data show that IL-1β cellular actions can be blocked by expression of MyD88 dominant negative proteins and, finally, that cytokine-induced β cell secretory dysfunctions are due to the action of IFN-γ.

[1]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[2]  G. Wilding,et al.  DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. , 1990, Analytical biochemistry.

[3]  J. Bonaventura,et al.  Chloride masks effects of opposing positive charges in Hb A and Hb Hinsdale (beta 139 Asn-->Lys) that can modulate cooperativity as well as oxygen affinity. , 1994, Journal of molecular biology.

[4]  N. Welsh,et al.  Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. , 1994, The Journal of clinical investigation.

[5]  S. Efrat,et al.  Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[7]  N. Welsh,et al.  Interleukin-1b-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. , 1996 .

[8]  D. Pipeleers,et al.  Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. , 1996, The Journal of clinical investigation.

[9]  M. Birnbaum,et al.  Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2 , 1997, Nature Genetics.

[10]  P. Feng,et al.  IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. , 1997, Science.

[11]  Z. Cao,et al.  MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. , 1997, Immunity.

[12]  B. Thorens,et al.  Dexamethasone Induces Posttranslational Degradation of GLUT2 and Inhibition of Insulin Secretion in Isolated Pancreatic β Cells , 1997, The Journal of Biological Chemistry.

[13]  D. Eizirik,et al.  Is there a role for nitric oxide in beta-cell dysfunction and damage in IDDM? , 1997, Diabetes/metabolism reviews.

[14]  G. Waeber,et al.  Fatty Acids Decrease IDX-1 Expression in Rat Pancreatic Islets and Reduce GLUT2, Glucokinase, Insulin, and Somatostatin Levels* , 1997, The Journal of Biological Chemistry.

[15]  C. Benoist,et al.  Cell Death Mediators in Autoimmune Diabetes—No Shortage of Suspects , 1997, Cell.

[16]  G. Waeber,et al.  IB1, a JIP-1-related Nuclear Protein Present in Insulin-secreting Cells* , 1998, The Journal of Biological Chemistry.

[17]  W. Suarez-Pinzon,et al.  Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. , 1998, Biochemical pharmacology.

[18]  D. Trono,et al.  Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.

[19]  P. Auron,et al.  The interleukin 1 receptor: ligand interactions and signal transduction. , 1998, Cytokine & growth factor reviews.

[20]  S. Takasawa,et al.  Transgenic Mice Overexpressing Type 2 Nitric-oxide Synthase in Pancreatic β Cells Develop Insulin-dependent Diabetes without Insulitis* , 1998, The Journal of Biological Chemistry.

[21]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[22]  S. Saccani,et al.  The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6) , 1998, The Journal of experimental medicine.

[23]  D. Eizirik,et al.  Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells , 1998, Diabetologia.

[24]  L. Rossetti,et al.  Functional analysis of a conditionally transformed pancreatic beta-cell line. , 1998, Diabetes.

[25]  F. Martinon,et al.  MyD88, an Adapter Protein Involved in Interleukin-1 Signaling* , 1998, The Journal of Biological Chemistry.

[26]  S. Efrat Cell-based therapy for insulin-dependent diabetes mellitus. , 1998, European journal of endocrinology.

[27]  David J. Anderson,et al.  Fate mapping of the mouse midbrain–hindbrain constriction using a site-specific recombination system , 1998, Current Biology.

[28]  D. Trono,et al.  Lentivirus-mediated Bcl-2 expression in βTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion , 1999, Gene Therapy.

[29]  M. Rothe,et al.  Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear Phagocytes* , 1999, The Journal of Biological Chemistry.

[30]  C. Mathieu,et al.  The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells. , 1999, European cytokine network.

[31]  A. Aderem,et al.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[33]  J. Katz,et al.  In Autoimmune Diabetes the Transition from Benign to Pernicious Insulitis Requires an Islet Cell Response to Tumor Necrosis Factor α , 1999, The Journal of experimental medicine.

[34]  D. Eizirik,et al.  Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. , 2000, Diabetes.

[35]  G. Waeber,et al.  IB1 Reduces Cytokine-induced Apoptosis of Insulin-secreting Cells* , 2000, The Journal of Biological Chemistry.

[36]  G. Holländer,et al.  Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage. , 2000, Diabetes.

[37]  C. Dina,et al.  The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes , 2000, Nature Genetics.